The BRIMANA brand, founded in 2004 (Japan), from 33 sister brands and 17477 competing brands. The BRIMANA brand is owned by Santen Pharmaceutical, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is JP3336000009. BRIMANA belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Santen Pharmaceutical
(BRIMANA)
over 5 years*
EUR 5.90